Gut and inflammation: Individuals with persistent digestive discomfort where gut barrier support is clinically relevant, people with suspected gut-inflammation overlap contributing to fatigue or poor systemic recovery, and those with a history of NSAID-related gut irritation
10.1016/S0031-9422(00)84698-1 [Google Scholar] Shi WQ, Li SD, Li GR, Wang WH, Chen QX, Li YQ, Ling XW (2016) Investigation of main factors affecting the growth rate of Spirulina
Addressing Regulatory Concerns The current "unapproved drug" status by the FDA and the bans by anti-doping agencies highlight the significant regulatory hurdles BPC-157 faces
Goldin E, Ardite E, Elizalde JI, Odriozola A, Panes J, Pique JM, and Fernndez-Checa JC (1997)